Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy
- 31 December 1989
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 35 (3) , 406-408
- https://doi.org/10.1016/0090-8258(89)90089-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Response to O-TRP-6-LHRH (decapeptyl) in dvarian cancerJournal of Steroid Biochemistry, 1987
- Gonadotrophin hormone releasing analogues open new doors in cancer treatment.BMJ, 1987
- Characterization of gonadotrophin receptors in a testosterone‐producing ovarian androblastoma. Case reportBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- GNRH-binding-sites in human epithelial ovarian carcinomaEuropean Journal of Cancer and Clinical Oncology, 1986
- Testosterone Secretion by Cultured Arrhenoblastoma Cells: Suppression by a Luteinizing Hormone-Releasing Hormone AgonistJournal of Clinical Endocrinology & Metabolism, 1982
- LH(hCG) Receptor in Benign and Malignant Tumors of Human OvaryActa Obstetricia et Gynecologica Scandinavica, 1981
- AN IMPROVED IN VITRO BIOASSAY METHOD FOR MEASURING LUTEINIZING HORMONE (LH) ACTIVITY USING MOUSE LEYDIG CELL PREPARATIONSActa Endocrinologica, 1974